Minimally invasive urinary incontinence device market seen reaching $1.91 billion by 2030

The Business Research Company says the minimally invasive urinary incontinence device market is growing quickly, with revenue projected to rise from $1.25 billion in 2025 to $1.37 billion in 2026. The report points to prostate cancer cases, aging populations and new device technologies as major drivers, with Asia-Pacific expected to be the fastest-growing region.

Why it matters: - The market addresses urinary leakage and bladder-control problems tied to aging, prostate cancer and post-surgical recovery. - Demand is rising for procedures that reduce surgical trauma, shorten recovery time and lower complication risk. - The report signals where device makers, investors and health systems may see the strongest growth through 2030.

What happened: - The Business Research Company released a 2026 market report on minimally invasive urinary incontinence devices. - The market is forecast to grow from $1.25 billion in 2025 to $1.37 billion in 2026, a 9.1% compound annual growth rate. - The market is projected to reach $1.91 billion by 2030, at an estimated 8.8% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - Minimally invasive urinary incontinence devices are used to treat or manage urinary incontinence through less invasive techniques than open surgery. - These devices can support the urethra, improve sphincter function or influence nerve activity. - They are typically implanted or applied through small incisions, injections or percutaneous approaches. - The approach is designed to reduce surgical trauma and speed recovery. - Historical growth has been supported by the dominance of traditional open surgery, limited device options, greater awareness of female pelvic health issues, more hospital and clinic procedures, and wider use of tension-free vaginal tape systems. - Future growth is expected from advanced mid-urethral and single-incision sling systems, more home healthcare device spending, a larger elderly population, higher incontinence rates, regulatory clearances for new bulking agents and artificial urinary sphincters, and smart and robotic-assisted surgical technologies. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - The report frames urinary incontinence as a broader healthcare problem rather than a niche urology category, linking demand to demographics and cancer care. - Prostate cancer stands out as a growth driver because treatment and recovery often create urinary complications that these devices can help manage. - The forecast suggests competition will increasingly center on less invasive systems, home-based care and technology-enabled procedures.

What's next: - Manufacturers are likely to focus on product development tied to sling systems, bulking agents, artificial urinary sphincters and robotic-assisted workflows. - Market momentum may continue to shift toward Asia-Pacific as aging populations and procedure adoption expand. - Health care providers may increase adoption of devices that reduce recovery time and surgical complications.

The bottom line: - The minimally invasive urinary incontinence device market is on track for steady expansion, with demographic pressure and device innovation driving demand through 2030.